BWV

Blue Water Vaccines, Inc. (BWV) | Rumor.io

Blue Water Vaccines

BWV

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about BWV?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Jun 15

$BWV was dabbled in for a new long strategy and a short position was considered but not executed.
A potential short strategy for $BWV is to sell at $1.50 and cover at $1.30, with a target short at $1.45.
$BWV ran +55.2% after being mentioned, squeezing to the $1.95 level.

Generated by AI

Sentiment

Of the messages about BWV that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	100% +50
Bearish	—	—	—	0% -50

Bullish· Feb 14

$BWV has the potential for significant price appreciation, with a 52-week high of $90 and a current price of around $1.70.
The company's development of a Marburg vaccine is driving the stock's upward momentum, with a small float and high short interest contributing to the potential for a multi-day play.
The stock's recent price action, including a 20.6% increase in just a few hours, suggests that it may be due for a breakout above the $1.75 level, with a potential test of $1.90.

Bearish· Feb 14

$BWV has a history of handing traders large losses, with one trader experiencing their worst loss on August 17 last year.
The stock's recent price action has been characterized by a "trappy" and volatile trading environment, with traders entering and exiting positions in response to various levels and gaps.
Traders are warning that $BWV is due for a significant decline, with some predicting a drop to $1.55-$1.50 if the stock breaks below $1.70, and others suggesting that the stock's 200-day moving average is approaching, potentially leading to a major decline.

Generated by AI

Topics

Of the messages about BWV that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0%
Announcements	—	—	—	100%
Controversies	—	—	—	0%
Earnings	—	—	—	0%
Macro	—	—	—	0%
Technical Analysis	—	—	—	0%

Earnings· May 4

Blue Water Vaccines, Inc. (BWV) is mentioned in a series of posts related to Affluence Corporation's (AFFU) Q1 earnings, which include record revenue and earnings for the second consecutive quarter.
The posts highlight Affluence Corporation's strong financial performance, but do not provide specific details about Blue Water Vaccines' earnings or performance.
The inclusion of BWV in the posts appears to be due to its being part of the same news announcement as Affluence Corporation's earnings report.

Announcements· Feb 14

Blue Water Vaccines, Inc. (BWV) announced the appointment of Frank Jaeger as Senior Vice President of Marketing and Business Development, effective immediately.
BWV is working on a vaccine for the Marburg virus and will be presenting at the WHO meeting today.
Founder, CEO, and Chairman Joseph Hernandez reported an 18.43% passive stake in BWV through a 13G filing.

Technical Analysis· Feb 14

$BWV has a strong support level at the previous resistance area, and it's holding above the high of the day.
The 5-minute chart for $BWV is showing a potential double bottom and a watch for a break above $1.75, which could lead to a test of $1.90.
$BWV is showing a down trend breakout into VWAP reclaim, with high volume, and a short bias if it doesn't break with volume.

Generated by AI

Community

Of the messages about BWV, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	0%
Newcomers	—	—	—	100%

Regulars· Jun 14

Blue Water Vaccines, Inc. (BWV) has expanded its commercial portfolio by acquiring six FDA-approved drugs across various treatment areas, enhancing its business prospects.
The regulars are focused on the potential for a breakout above $2, with a 60% win probability and medium conviction, targeting a cross at $1.90 for a subsequent move to $2+.
BWV has shown significant momentum, with a +119.0% pre-market move and a +55.2% intraday increase, indicating strong market interest and potential for further gains.

Newcomers· Feb 15

The newcomer is watching $BWV for potential gains at the open, mentioning it alongside another stock.
The newcomer had a mixed trading session, noting a win on $BWV but also a loss on $HYPR, and is pleased with their read on the stock.
The newcomer reports a 32.20% gain over 4 weeks on $BWV, following an A.I.dvisor bullish call on the stock.

Generated by AI

Also Discussed

Investors talking about BWV also mention

#	Name	Attention
1	Comera Life Sciences Holdings Inc.CMRA	0%0
2	Sky Harbour Group Corp.SKYH	0%new
3	GeoVax Labs, Inc.GOVX	0%+0
4	Hour Loop, Inc.HOUR	0.01%0
5	System1 Inc.SST	0%0
6	PaxMedica Inc.PXMD	0%0
7	FWBI - First Wave BioPharma, Inc.	——
8	Imperial Petroleum Inc.IMPP	0%0
9	SuperCom Ltd.SPCB	0%+0
10	Lixte Biotechnology Holdings Inc.LIXT	0%new